Skip to content

Evaluation of a Novel Bionic Foot, AMPfoot 4+

Prospective Case Study: Adaptation Period of a Novel Motorized Ankle Prosthesis, AMPfoot 4+

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03530956
Enrollment
1
Registered
2018-05-21
Start date
2016-10-01
Completion date
2016-12-15
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Change, Physical Activity, Prosthesis User

Keywords

AMPfoot, dual-task, cognitive performance, physical performance, lower-limb prosthesis

Brief summary

Background: Evaluating the use of a novel motorized ankle prosthesis during walking and under dual task circumstances is an important step in product development. Objective: To iteratively evaluate the effectiveness of a novel bionic foot, the Ankle Mimicking Prosthetic device 4+ (or AMPfoot 4+), during walking. Study design: Case study (crossover) research design. Methods: One male subject will conduct a baseline experimental trial with the current prosthetic device and several experimental trials with the AMPfoot 4+ to evaluate the effectiveness of the novel device and investigate the adaptation period. Prior to baseline experiments, a familiarization trial will be performed to determine intra-subject variability of the dual task. An experimental trial consists of 2 walking tasks, i.e. the 6-minute walk test (6MWT) and the 10-meter walk test. The 6MWT will be combined with a cognitive task, i.e. backwards counting, to create dual task circumstances. The outcome measurements for the dual task are the distance covered and the walking speed, heart rate (HR) (Polar), rating of perceived exertion (RPE), VO2 (Cosmed K5), electro-encephalography (EEG), electro-myography (EMG), electro-cardiography (ECG), electrodermal activity (/skin conductance),accuracy and total duration of the cognitive task, BodyMedia (physical activity) and the visual analogue scale (VAS) for fatigue and comfort. A 10-meter walk test will be evaluated on duration. Expected findings: In a first phase the novel device will probably reduce walking and cognitive performance, whereas fine-tuning the mechatronics (after several retests) should improve walking and cognitive performance during walking.

Interventions

DEVICEAnkle Mimicking Prosthetic Foot prototype 4+

The amputee will walk with AMPfoot 4+, a novel bionic foot, designed and built by an engineer of department MECH (VUB, B)

Sponsors

Vrije Universiteit Brussel
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* unilateral transtibial (below knee) amputee * healthy subject * K4-level (Medicare), which means highest ambulation level

Exclusion criteria

* comorbidities * pain in stump

Design outcomes

Primary

MeasureTime frameDescription
Walking speed of a 10 meter walk testThrough study completion, a period of 8 monthsWalking speed during a 10 meter walk test
Duration of backward counting during walking (dual task)Through study completion, a period of 8 monthsDuration of the cognitive task backward counting
Walking distance of a 6 minute walk testThrough study completion, a period of 8 monthsDistance walked during a 6 minute hallway walk test
Walking speed of a 6 minute walk testThrough study completion, a period of 8 monthsWalking speed during a 6 minute walk test
Accuracy of backward counting during walking (dual task)Through study completion, a period of 8 monthsAccuracy of responses of the cognitive task
Heart rate during walking tasksThrough study completion, a period of 8 monthsHeart rate during 6 minute and 10m walk tests
Rating of Perceived Exertion during walking tasksThrough study completion, a period of 8 monthsRating of Perceived Exertion ranges from 6 (no exertion) until 20 (maximal exertion) during 6 minute and 10m walk tests. Higher values indicate a higher subjective feeling of exertion.
Oxygen consumption (VO2) during 6 minute walk testThrough study completion, a period of 8 monthsVO2 during 6 minute walk test
Visual analogue scale for fatigue during 6 min walk testThrough study completion, a period of 8 monthsValue at a scale (from 1 to 10) is provided using an X (as sign) and determines level of fatigue during walking. The higher the value the higher the level of fatigue
Visual analogue scale for comfort during 6 min walk testThrough study completion, a period of 8 monthsValue at a scale (from 1 to 10) is provided using an X (as sign) and determines level of comfort during walking. The higher the value the higher the level of comfort.
Brain activityThrough study completion, a period of 8 monthsNon-invasive electro-encephalography during walking
Muscle activityThrough study completion, a period of 8 monthsNon-invasive electro-myography during walking
Heart activityThrough study completion, a period of 8 monthsNon-invasive electro-cardiography during walking
Electrodermal activityThrough study completion, a period of 8 monthsSkin sensor during walking determines level of arousal

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026